Investigating the role of PPM1D mutations in blood cell development and cancer risk
PPM1D in Clonal Hematopoiesis and Malignancies
This study is looking at how changes in a specific gene called PPM1D might affect blood stem cells in people with clonal hematopoiesis, especially after they've had chemotherapy, to help find better ways to prevent blood cancers like leukemia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10655461 on NIH RePORTER |
What this research studies
This research focuses on clonal hematopoiesis (CH), a condition where certain blood stem cells dominate blood production, increasing the risk of blood cancers. The study aims to understand how mutations in the PPM1D gene, which have been linked to these cancers, affect the behavior of blood stem cells, especially after chemotherapy. By using cellular, animal, and human patient studies, the researchers hope to uncover the mechanisms by which PPM1D mutations contribute to the development of leukemia and other malignancies. This could lead to better understanding and potential new treatments for patients at risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with clonal hematopoiesis or those who have developed secondary leukemias after chemotherapy.
Not a fit: Patients without clonal hematopoiesis or those not at risk for hematologic malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating blood cancers in patients with clonal hematopoiesis.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors contributing to blood cancers, making this approach both relevant and potentially impactful.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Goodell, Margaret a. — Baylor College of Medicine
- Study coordinator: Goodell, Margaret a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.